# AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease

Study · id `cardio:ct-nct07512206` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07512206](<https://clinicaltrials.gov/study/NCT07512206>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07512206

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07512206. Allocation not applicable; no masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2026-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07512206, source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)
- Planned start: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT07512206, source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)
- Primary completion: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07512206, source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)
- Completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT07512206, source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07512206, source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07512206-2026-04-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
- Acronym: AERO CAD
- Condition: Coronary Artery Disease (CAD)
- Condition: Coronary Calcification
- Condition: Coronary Calcified Disease
- Condition: Coronary Calcified Nodules
- Intervention (Device): Shockwave C2 Aero Coronary IVL System
- Lead sponsor: OPCI Core Laboratories LLC
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 71922765d5a08d0fd592d9cc4ceca893f46bfaf878605328feea9003a2c3b450
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
